Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration

Immunogenicity of AAV vectors renders repeated AAV dosing ineffective. Here the authors show that coadministration of nanoparticle-encapsulated rapamycin overcomes AAV immunogenicity through Treg induction, enabling efficient AAV redosing in mice and nonhuman primates.

Guardado en:
Detalles Bibliográficos
Autores principales: Amine Meliani, Florence Boisgerault, Romain Hardet, Solenne Marmier, Fanny Collaud, Giuseppe Ronzitti, Christian Leborgne, Helena Costa Verdera, Marcelo Simon Sola, Severine Charles, Alban Vignaud, Laetitia van Wittenberghe, Giorgia Manni, Olivier Christophe, Francesca Fallarino, Christopher Roy, Alicia Michaud, Petr Ilyinskii, Takashi Kei Kishimoto, Federico Mingozzi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/8c201057906f4f2d8d990ffb8e12cbae
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8c201057906f4f2d8d990ffb8e12cbae
record_format dspace
spelling oai:doaj.org-article:8c201057906f4f2d8d990ffb8e12cbae2021-12-02T17:31:43ZAntigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration10.1038/s41467-018-06621-32041-1723https://doaj.org/article/8c201057906f4f2d8d990ffb8e12cbae2018-10-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-06621-3https://doaj.org/toc/2041-1723Immunogenicity of AAV vectors renders repeated AAV dosing ineffective. Here the authors show that coadministration of nanoparticle-encapsulated rapamycin overcomes AAV immunogenicity through Treg induction, enabling efficient AAV redosing in mice and nonhuman primates.Amine MelianiFlorence BoisgeraultRomain HardetSolenne MarmierFanny CollaudGiuseppe RonzittiChristian LeborgneHelena Costa VerderaMarcelo Simon SolaSeverine CharlesAlban VignaudLaetitia van WittenbergheGiorgia ManniOlivier ChristopheFrancesca FallarinoChristopher RoyAlicia MichaudPetr IlyinskiiTakashi Kei KishimotoFederico MingozziNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Amine Meliani
Florence Boisgerault
Romain Hardet
Solenne Marmier
Fanny Collaud
Giuseppe Ronzitti
Christian Leborgne
Helena Costa Verdera
Marcelo Simon Sola
Severine Charles
Alban Vignaud
Laetitia van Wittenberghe
Giorgia Manni
Olivier Christophe
Francesca Fallarino
Christopher Roy
Alicia Michaud
Petr Ilyinskii
Takashi Kei Kishimoto
Federico Mingozzi
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
description Immunogenicity of AAV vectors renders repeated AAV dosing ineffective. Here the authors show that coadministration of nanoparticle-encapsulated rapamycin overcomes AAV immunogenicity through Treg induction, enabling efficient AAV redosing in mice and nonhuman primates.
format article
author Amine Meliani
Florence Boisgerault
Romain Hardet
Solenne Marmier
Fanny Collaud
Giuseppe Ronzitti
Christian Leborgne
Helena Costa Verdera
Marcelo Simon Sola
Severine Charles
Alban Vignaud
Laetitia van Wittenberghe
Giorgia Manni
Olivier Christophe
Francesca Fallarino
Christopher Roy
Alicia Michaud
Petr Ilyinskii
Takashi Kei Kishimoto
Federico Mingozzi
author_facet Amine Meliani
Florence Boisgerault
Romain Hardet
Solenne Marmier
Fanny Collaud
Giuseppe Ronzitti
Christian Leborgne
Helena Costa Verdera
Marcelo Simon Sola
Severine Charles
Alban Vignaud
Laetitia van Wittenberghe
Giorgia Manni
Olivier Christophe
Francesca Fallarino
Christopher Roy
Alicia Michaud
Petr Ilyinskii
Takashi Kei Kishimoto
Federico Mingozzi
author_sort Amine Meliani
title Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
title_short Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
title_full Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
title_fullStr Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
title_full_unstemmed Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
title_sort antigen-selective modulation of aav immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/8c201057906f4f2d8d990ffb8e12cbae
work_keys_str_mv AT aminemeliani antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT florenceboisgerault antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT romainhardet antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT solennemarmier antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT fannycollaud antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT giusepperonzitti antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT christianleborgne antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT helenacostaverdera antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT marcelosimonsola antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT severinecharles antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT albanvignaud antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT laetitiavanwittenberghe antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT giorgiamanni antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT olivierchristophe antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT francescafallarino antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT christopherroy antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT aliciamichaud antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT petrilyinskii antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT takashikeikishimoto antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
AT federicomingozzi antigenselectivemodulationofaavimmunogenicitywithtolerogenicrapamycinnanoparticlesenablessuccessfulvectorreadministration
_version_ 1718380503920279552